Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2023 September;65(3) > Panminerva Medica 2023 September;65(3):426-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   Free accessfree

Panminerva Medica 2023 September;65(3):426-7

DOI: 10.23736/S0031-0808.21.04624-3

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

The clinical effect of Xuezhikang combined with ezetimibe in the treatment of coronary heart disease in lipid-lowering treatment and its influence on blood lipid level

Liling GUO, Shuping ZHAO, Wang ZHAO

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China



top of page